| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Humacyte, Inc. (HUMA) has 14 insiders with recent SEC Form 4 filings, including 4 buys and 15 sells. HUMA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 318.6K | $360.0K | - | |
| CFO | 313.1K | $353.8K | - | |
| Dir | 311.1K | $351.5K | - | |
| CEO | 311.1K | $351.5K | - | |
| Dir | 80.0K | $90.4K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 20, 2024 | Niklason Laura E66 | President, CEO And Director | Sell | 1,500,000 | $4.40 | $6,606,799.34 | -19.6% | -15.0% | -74.6% | |
| Nov 19, 2024 | Niklason Laura E66 | President, CEO And Director | Buy | 1,797 | $4.44 | $7,978.68 | +0.7% | -15.2% | -73.5% | |
| Nov 19, 2024 | Dougan Brady W60 | Director | Buy | 1,797 | $4.44 | $7,978.68 | +0.7% | -15.2% | -73.5% | |
| Sep 10, 2024 | Sebelius Kathleen | Director | Sale+OE | 5,182 | $5.40 | $28,003.66 | -6.0% | -19.7% | -71.8% | |
| Sep 10, 2024 | Niklason Laura E66 | President, CEO And Director | Sell | 446,378 | $5.30 | $2,364,520.70 | -6.2% | -19.7% | -71.8% | |
| Sep 10, 2024 | Dougan Brady W60 | Director | Sell | 446,378 | $5.30 | $2,364,520.70 | -6.2% | -19.7% | -71.8% | |
| Aug 29, 2024 | Niklason Laura E66 | President, CEO And Director | Buy | 1,222 | $6.55 | $7,997.99 | +0.5% | -28.5% | -74.8% | |
| Aug 29, 2024 | Dougan Brady W60 | Director | Buy | 1,222 | $6.55 | $7,997.99 | +0.5% | -28.5% | -74.8% | |
| Aug 29, 2024 | Niklason Laura E66 | President, CEO And Director | Sell | 881,878 | $6.49 | $5,724,139.46 | -6.8% | -28.5% | -74.8% | |
| Aug 29, 2024 | Dougan Brady W60 | Director | Sell | 881,878 | $6.49 | $5,724,139.46 | -6.8% | -28.5% | -74.8% |